Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 1 min ago
Peer-reviewedCC BYMolecular therapy. Nucleic acids

Bridging the antiviral gap: A BAC-based non-infectious SARS-CoV-2 replicon reveals potent antisense gapmers

  • Agnieszka Ruszkowska1
  • Agnieszka Baliga-Gil1
  • Julita Piasecka1
  • Maria Ciechanowska1
  • Ryszard Kierzek1
  • Elzbieta Kierzek1
  1. 1Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland
Read full textPDFCite

Related

  1. Cell-resolved pharmacodynamic profiling reveals tissue- and cell-population-specific activity of antisense oligonucleotide chemical conjugates in vivo
    S. Cheng, J. Frommer, A. Eddaoudi +4
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  2. Experimental validation of computationally prioritized bisphosphonates reveals no direct in vitro antiviral activity against SARS-CoV-2
    M. M.-U.- Rehman, S. Olliff, A. McAuley +4
    bioRxivPreprintCC BY-NCFull textMolecular biology & gene regulationbioRxiv
  3. Thiomorpholino antisense oligonucleotides inhibit telomerase and limit cancer cell proliferation
    J. Rivosecchi, A. J. Zaug, T. Lasek +3
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  4. Antisense oligonucleotides targeting transcription termination windows disrupt mRNA 3’ end processing and decrease gene expression
    Kinga Winczura, Lars Joenson, Erich Koller +2
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full text2 citedMolecular biology & gene regulationCrossref
  5. Decoy and antisense RNA oligonucleotides targeting the EGFR exon 3 splice site suppress proliferation of A172 glioblastoma cells
    Y. Nishi, Y. Horita, H. Harada +3
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv

Cite

BibTeXRIS
BibTeX
@article{ruszkowska2026bridging,
  title = {{Bridging the antiviral gap: A BAC-based non-infectious SARS-CoV-2 replicon reveals potent antisense gapmers}},
  author = {Agnieszka Ruszkowska and Agnieszka Baliga-Gil and Julita Piasecka and Maria Ciechanowska and Ryszard Kierzek and Elzbieta Kierzek},
  journal = {Molecular therapy. Nucleic acids},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13656313},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Bridging the antiviral gap: A BAC-based non-infectious SARS-CoV-2 replicon reveals potent antisense gapmers
AU  - Agnieszka Ruszkowska
AU  - Agnieszka Baliga-Gil
AU  - Julita Piasecka
AU  - Maria Ciechanowska
AU  - Ryszard Kierzek
AU  - Elzbieta Kierzek
PY  - 2026
DA  - 2026/09/15
JO  - Molecular therapy. Nucleic acids
UR  - https://europepmc.org/article/PMC/PMC13656313
SN  - 2162-2531
ER  -